Young-onset diabetes presents unique challenges in diagnosis, classification, and management, particularly due to its clinical and genetic heterogeneity.
When is the best time of day to work out to improve blood sugar? Learn what research says about exercise timing and blood ...
Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...
As cannabis legalization expands nationally, what should your patients with diabetes know about the risks and benefits?
Frequent CGM use ties to bigger A1c drops in type 2 diabetes, even across GLP-1, SGLT2, and insulin regimens. In this episode ...
Prediabetes affects 634.8 million adults globally, i.e., approximately 12% of the adult population (IDF, 2025), with 30.4% ...
Hosted on MSN
ADA backs CGM use from type 2 diabetes diagnosis
The American Diabetes Association’s 2026 Standards of Care now recommend continuous glucose monitoring (CGM) for all newly diagnosed type 2 diabetes patients, expanding its use beyond ...
The American Diabetes Association’s 2026 Standards of Care reframe type 2 diabetes as a multi-system condition, integrating cardiovascular, kidney, and metabolic risk management. The guidelines ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Diabetes Leadership Council (DLC), a patient advocacy organization dedicated to advancing patient-first policies at the local, state, and national levels, issued a timely call-to-action report on how ...
Tandem Diabetes Care (Nasdaq:TNDM) today announced FDA clearance for its automated insulin delivery technology for use in ...
The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts. By Angelica P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results